Canada markets open in 38 minutes

Mind Medicine (MindMed) Inc. (MMDCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.06500.0000 (0.00%)
At close: 09:46AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.6800
Open0.0600
BidN/A x N/A
AskN/A x N/A
Day's Range0.0650 - 0.9900
52 Week Range0.0650 - 0.9900
Volume551
Avg. VolumeN/A
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    MindMed Announces Completion of Share Redesignation

    Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED) ("MindMed'' or the "Company") announces that it has completed its previously announced redesignation of its subordinate voting shares as common shares (the "Common Shares") of the Company. The Common Shares will be assigned CUSIP number 60255C802 and ISIN number CA60255C8025 following the redesignation. The Common Shares will begin trading on a post-Redesignation basis under the new CUSIP and ISIN numbers on the NEO Exchange and NASDAQ at m

  • CNW Group

    Mindmed Announces Voting Results for Annual General and Special Meeting

    Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), announces the voting results of the Company's annual general and special meeting of shareholders held on June 1, 2022 (the "Meeting").

  • CNW Group

    MindMed to Participate in the Jefferies Global Healthcare Conference

    Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that Robert Barrow, Chief Executive Officer and Director, will participate in the Jefferies Global Healthcare Conference, to be held in New York, NY from June 8-10, 2022.